Mumbai, Aug. 25 -- Sai Parenterals has announced that its Australian subsidiary, Noumed Pharmaceuticals, has renewed its OTC Medicines Supply Agreement with one of Australia's leading, multi-billion-dollar pharmacy chains. The renewal carries an expanded product portfolio, a long agreement tenure and a higher agreement value, and is projected at AUD 30 million (approximately INR 204.0 crore; 1 AUD = INR 68) over a three-year term, effective immediately.

Published by HT Digital Content Services with permission from Capital Market....